Literature DB >> 2435657

Exaggerated renal vasodilator response to calcium entry blockade in first-degree relatives of essential hypertensive subjects.

J L Blackshear, D Garnic, G H Williams, D P Harrington, N K Hollenberg.   

Abstract

Because an inherited renal factor may contribute to essential hypertension in humans, the study of family members is attractive. To assess the determinants of renal vascular tone, graded doses of either diltiazem (10-1000 micrograms/min) or acetylcholine (1-100 micrograms/min) were infused into the renal artery in 52 normotensive subjects, 16 with and 36 without a family history of hypertension when they were in balance on either a 10-mEq or 200-mEq sodium intake. Renal blood flow was measured with 133Xe. Restricted sodium intake potentiated renal vascular responses to diltiazem (p less than 0.01), suggesting a role for angiotensin as a determinant. In four subjects with no family history of hypertension on a 200-mEq sodium intake, angiotensin II in subpressor doses (1 ng/kg/min i.v.) induced renal vasoconstriction and enhanced the renal vasodilator action of diltiazem (p less than 0.001). In subjects with a family history of hypertension, the renal vascular response to diltiazem was enhanced (p less than 0.01) despite similar values of plasma renin activity, angiotensin II concentration, and sodium excretion. Because responses to acetylcholine were modified neither by sodium intake nor by family history, specificity for diltiazem was suggested. The intriguing possibility is raised that the enhanced renal vascular response to diltiazem reflects an abnormality in the control of renal vascular tone in the offspring of essential hypertensive subjects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435657     DOI: 10.1161/01.hyp.9.4.384

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

Review 1.  Renal effects of calcium entry blockers.

Authors:  L M Ruilope; J M Alcazar
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

Authors:  M M Buckley; S M Grant; K L Goa; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 3.  Hypertension and the kidney.

Authors:  D E Wesson
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 4.  Effects of calcium antagonists on the hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

Review 5.  Renal protection by antihypertensive therapy.

Authors:  Luis M Ruilope; Julian Segura
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.